Onconova Therapeutics, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 3.68%219.840.0%$2043.98m
BIIBBiogen, Inc. -5.41%351.791.7%$1219.11m
NVAXNovavax, Inc. -0.77%190.7679.8%$814.05m
SNSSSunesis Pharmaceuticals, Inc. 4.09%11.590.7%$810.18m
AMGNAmgen, Inc. 1.03%241.161.3%$643.95m
BNTXBioNTech SE -1.06%227.060.0%$566.85m
VRTXVertex Pharmaceuticals, Inc. 2.58%192.351.9%$541.22m
GILDGilead Sciences, Inc. 1.17%67.431.0%$481.39m
REGNRegeneron Pharmaceuticals, Inc. 2.13%541.082.7%$394.34m
OCGNOcugen, Inc. 5.03%7.940.0%$363.15m
ILMNIllumina, Inc. 0.23%470.213.5%$347.73m
ALXNAlexion Pharmaceuticals, Inc. 0.53%180.792.0%$333.49m
EXASEXACT Sciences Corp. -0.15%130.7818.1%$175.79m
TXG10X Genomics, Inc. -2.49%196.400.0%$174.27m
BNGOBionano Genomics, Inc. -0.55%7.210.0%$155.26m

Company Profile

Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.